Krop og Hormoner ApS: Financial statements 2022
CVR: 38683446
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Krop og Hormoner ApS (CVR 38683446) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -15,617 compared with DKK 124,350 the year before. Equity in the 2022 report amounted to DKK 1,002,217. The solvency ratio was 84.5%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -15,617
- Equity
- DKK 1,002,217
- Total Assets
- DKK 1,185,817
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -16K | 1M | 1 |
| 2021 | - | -9K | 124K | 1M | 1 |
| 2020 | - | -9K | 801K | 893K | 1 |
| 2019 | - | -6K | 55K | 93K | 1 |
| 2018 | - | - | -6K | 37K | 1 |
Official annual report
Keep an eye on Krop og Hormoner ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Krop og Hormoner ApS has published its annual report for 2021. Gross profit came to DKK -9,135, and the net result was DKK 124,350.
About Krop og Hormoner ApS
Krop og Hormoner ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2017. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named GDL Holding ApS. The management consists of Gitte Elbæk Kobbelgaard Dalberg-Larsen. The company is owned by Gitte Elbæk Kobbelgaard Dalberg-Larsen. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 10,394 and a net result of DKK 2,227 compared with DKK 68,042 the year before. Equity in the 2025 report amounted to DKK 3,700,443.